RayanaAI
Account
RVTY
HOLD / NEUTRALMeanRev
Composite
51.70
Technical
81.50
Fundamental
41.70
Rank
—
Price
111.39
Hurst
0.32
As of
Aug 5, 2026
Daily
Revvity, Inc.
HealthcareDiagnostics & Research

Revvity provides diagnostic instruments, reagents, software, and related services for healthcare and life sciences applications. The company's offerings include platforms for infectious disease testing, genetic screening, and detection of conditions ranging from pregnancy complications to rare metabolic disorders, along with genomic analysis tools used in oncology and drug discovery. Its products serve pharmaceutical companies, diagnostic laboratories, research institutions, and healthcare providers under numerous brand names across immunodiagnostics, molecular testing, and laboratory automation.

Market cap
$17.5B
P/E (trailing)
75.12
P/E (forward)
26.64
PEG ratio
0.73
Dividend yield
18.00%
Beta
1.06
52w range
81.22 – 169.06
Return on equity
+3.21%
Profit margin
+8.16%
Revenue growth
+1.30%
Earnings growth
+1.20%
Price history

1Y: 157.00 (+68.2%) · range 82.17–165.78

Cycle position
68/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 0 · NOT READY · exit proximity 15

Conviction
15/ 100 · maturity 0%
Buildup.3314
EMA entry setup.420
Fundamentals.2542
Volume profile
POC
111.92
Price vs POC
+40.3%
Overhead supply
7%
Runway
open sky

Value area 92.87–144.68 · 7% of 120d volume overhead · clean runway

Contributing sources

No source detections in the last 21 days.

Forward returns
HorizonReturnMFEState
20d+13.84%+13.84%mature
40d+29.59%+32.92%mature